NAF has launched a petition on Change.org calling on the FDA to prioritize treatment options for rare diseases with urgent unmet needs, including Spinocerebellar Ataxia (SCA).
SIGN THE PETITION
NAF has launched a petition on Change.org calling on the FDA to prioritize treatment options for rare diseases with urgent unmet needs, including Spinocerebellar Ataxia (SCA).
SIGN THE PETITION
CENTRAL TIME ZONE
This webinar will provide information about Arrowhead Pharmaceuticals’ ongoing Phase 1 study of ARO-ATXN2 in patients with Spinocerebellar Ataxia Type 2 (SCA2), including the rationale for an siRNA therapeutic approach, an overview of the study design and eligibility requirements for participation, and how patients can contact sites to learn more.
Register: Click here.
Other Webinars
NAF hosts educational webinars about Ataxia presented by industry experts. Learn about important topics related to living with Ataxia. Webinars are complimentary for NAF members, with new sessions offered each month. Join NAF to receive invitations to upcoming Ataxia webinars. Visit www.ataxia.org/webinars to explore past webinars on a variety of topics.
